According to Recro Pharma 's latest financial reports the company's current revenue (TTM) is S$98.15 M. In 2020 the company made a revenue of S$86.61 M a decrease over the revenue in the year 2019 that were of S$0.12 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.